The DOI matches its Crossref record; 235 of the 235 references it cites were found in a registry or an index.
MicroRNA and cancer
Open accessAbstract
With the advent of next generation sequencing techniques a previously unknown world of non‐coding RNA molecules have been discovered. Non‐coding RNA transcripts likely outnumber the group of protein coding sequences and hold promise of many new discoveries and mechanistic explanations for essential biological phenomena and pathologies. The best characterized non‐coding RNA family consists in humans of about 1400 microRNAs for which abundant evidence have demonstrated fundamental importance in normal development, differentiation, growth control and in human diseases such as cancer. In this review, we summarize the current knowledge and concepts concerning the involvement of microRNAs in cancer, which have emerged from the study of cell culture and animal model systems, including the regulation of key cancer‐related pathways, such as cell cycle control and the DNA damage response. Importantly, microRNA molecules are already entering the clinic as diagnostic and prognostic biomarkers for patient stratification and also as therapeutic targets and agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–235 of 235
Mishra, P. J., Mishra, P. J., Banerjee, D., & Bertino, J. R. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5666 · Cited by 201
Swarbrick, A., Woods, S. L., Shaw, A., Balakrishnan, A., Phua, Y., Nguyen, A., Chanthery, Y., Lim, L., Ashton, L. J., Judson, R. L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2227 · Cited by 201
Intact p53-Dependent Responses in miR-34–Deficient Mice
Concepcion, C. P., Han, Y.-C., Mu, P., Bonetti, C., Yao, E., D'Andrea, A., Vidigal, J. A., Maughan, W. P., Ogrodowski, P., & Ventura, A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002797 · Cited by 197
CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation
Burns, D. M., D’Ambrogio, A., Nottrott, S., & Richter, J. D. (2011) · Nature · doi:10.1038/nature09908 · Cited by 193
miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress
Xiao, J., Lin, H., Luo, X., Luo, X., & Wang, Z. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.347 · Cited by 189
MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN
Liu, B., Wu, X., Liu, B., Wang, C., Liu, Y., Zhou, Q., & Xu, K. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.07.019 · Cited by 184
The Tumor Suppressors p53, p63, and p73 Are Regulators of MicroRNA Processing Complex
Boominathan, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010615 · Cited by 178
Diederichs, S., & Haber, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0537 · Cited by 176
miR-200b mediates post-transcriptional repression of ZFHX1B
Christoffersen, N. R., Silahtaroglu, A., Ørom, U. A., Kauppinen, S., & Lund, A. H. (2007) · RNA · doi:10.1261/rna.586807 · Cited by 175
Self-citationMunker, R., & Calin, G. A. (2011) · Clinical Science · doi:10.1042/cs20110005 · Cited by 174
Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels
Muralidhar, B., Goldstein, L., Ng, G., Winder, D., Palmer, R., Gooding, E., Barbosa‐Morais, N., Mukherjee, G., Thorne, N., Roberts, I., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2179 · Cited by 173
Wynendaele, J., Böhnke, A., Leucci, E., Nielsen, S. J., Lambertz, I., Hammer, S., Sbrzesny, N., Kubitza, D., Wolf, A., Gradhand, E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0527 · Cited by 170
Self-citationMutant p53 drives invasion in breast tumors through up-regulation of miR-155
Neilsen, P. M., Noll, J. E., Mattiske, S., Bracken, C. P., Gregory, P. A., Schulz, R. B., Lim, S. P., Kumar, R., Suetani, R. J., Goodall, G. J., et al. (2013) · Oncogene · doi:10.1038/onc.2012.305 · Cited by 167
Laneve, P., Di Marcotullio, L., Gioia, U., Fiori, M. E., Ferretti, E., Gulino, A., Bozzoni, I., & Caffarelli, E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700071104 · Cited by 165
miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression
Pickering, M. T., Stadler, B. M., & Kowalik, T. F. (2009) · Oncogene · doi:10.1038/onc.2008.372 · Cited by 164
Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo
Lambertz, I., Nittner, D., Mestdagh, P., Denecker, G., Vandesompele, J., Dyer, M. A., & Marine, J.-C. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.202 · Cited by 163
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
Sotiropoulou, G., Pampalakis, G., Lianidou, E. S., & Mourelatos, Z. (2009) · RNA · doi:10.1261/rna.1534709 · Cited by 158
MicroRNAs and Stem Cells: Control of Pluripotency, Reprogramming, and Lineage Commitment
Heinrich, E.-M., & Dimmeler, S. (2012) · Circulation Research · doi:10.1161/circresaha.111.243394 · Cited by 151
Bui, T. V., & Mendell, J. T. (2010) · Genes & Cancer · doi:10.1177/1947601910377491 · Cited by 144
Cell cycle control and beyond: emerging roles for the retinoblastoma gene family
Genovese, C., Trani, D., Caputi, M., & Claudio, P. P. (2006) · Oncogene · doi:10.1038/sj.onc.1209652 · Cited by 142
MicroRNA profiling for the identification of cancers with unknown primary tissue‐of‐origin
Ferracin, M., Pedriali, M., Veronese, A., Zagatti, B., Gafà, R., Magri, E., Lunardi, M., Munerato, G., Querzoli, G., Maestri, I., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2915 · Cited by 135
The Therapeutic Potential of MicroRNAs in Cancer
Thorsen, S. B., Obad, S., Jensen, N. F., Stenvang, J., & Kauppinen, S. (2012) · Cancer Journal · doi:10.1097/ppo.0b013e318258b5d6 · Cited by 127
Benetti, R., Gonzalo, S., Jaco, I., Muñoz, P., González, S., Schoeftner, S., Murchison, E. P., Andl, T., Chen, T., Klatt, P., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0908-998b · Cited by 121
miR‐155/BIC as an oncogenic microRNA
Tam, W., & Dahlberg, J. E. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20282 · Cited by 113
Kitade, Y., & Akao, Y. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10r12fm · Cited by 105
Multiple E2F-Induced MicroRNAs Prevent Replicative Stress in Response to Mitogenic Signaling
Bueno, M. J., de Cedrón, M. G., Laresgoiti, U., Fernández‐Piqueras, J., Zubiaga, A. M., & Malumbres, M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01372-09 · Cited by 103
Small Regulatory RNAs May Sharpen Spatial Expression Patterns
Levine, E., McHale, P. T., & Levine, H. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030233 · Cited by 101
Leucci, E., Zriwil, A., Gregersen, L. H., Jensen, K. T., Obad, S., Bellan, C., Leoncini, L., Kauppinen, S., & Lund, A. H. (2012) · Oncogene · doi:10.1038/onc.2012.15 · Cited by 89
Self-citationWee, E. J. H., Peters, K. M., Nair, S. S., Hulf, T., Stein, S. R., Wagner, S., Bailey, P. J., Lee, S., Qu, W. J., Brewster, B. L., et al. (2012) · Oncogene · doi:10.1038/onc.2011.584 · Cited by 87
Nittner, D., Lambertz, I., Clermont, F. F., Mestdagh, P., Köhler, C., Nielsen, S. J., Jochemsen, A. G., Speleman, F., Vandesompele, J., Dyer, M. A., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2556 · Cited by 84
Laganà, A., Russo, F., Sismeiro, C., Giugno, R., Pulvirenti, A., & Ferro, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011166 · Cited by 64
Control of microRNA biogenesis and transcription by cell signaling pathways
Saj, A., & Lai, E. C. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.04.010 · Cited by 60
Are microRNAs located in genomic regions associated with cancer?
Lamy, P., Andersen, C. L., Dyrskjøt, L., Tørring, N., Orntoft, T. F., & Wiuf, C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603381 · Cited by 55
Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer
Garré, P., Pérez‐Segura, P., Díaz‐Rubio, E., Caldés, T., & de la Hoya, M. (2010) · Nature Genetics · doi:10.1038/ng1010-817 · Cited by 29
Spatiotemporal Aspects of MicroRNA-Mediated Gene Regulation
Pothof, J., & van Gent, D. C. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0332-6_5 · Cited by 8
Cited by
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
Hong, D. S., Kang, Y.-K., Borad, M., Sachdev, J., Ejadi, S., Lim, H. Y., Brenner, A. J., Park, K., Lee, J.-L., Kim, T.-Y., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0802-1 · Cited by 975
Beg, M. S., Brenner, A. J., Sachdev, J., Borad, M., Kang, Y.-K., Stoudemire, J., Smith, S., Bader, A. G., Kim, S., & Hong, D. S. (2017) · Investigational New Drugs · doi:10.1007/s10637-016-0407-y · Cited by 897
Bertoli, G., Cava, C., & Castiglioni, I. (2015) · Theranostics · doi:10.7150/thno.11543 · Cited by 815
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Chen, Y., Gao, D.-Y., & Huang, L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.009 · Cited by 672
MicroRNA and cancer – A brief overview
Acunzo, M., Romano, G., Wernicke, D., & Croce, C. M. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.09.013 · Cited by 630
Metadata
- Authors
- Jansson, M. D., & Lund, A. H.
- Venue
- Molecular Oncology
- Publisher
- Wiley
- Published
- 2012-10-09
- Volume
- 6
- Issue
- 6
- Pages
- 590-610
- ISSN
- 1574-7891 (ISSN-L)
- 1878-0261
- OpenAlex
- W1969192247
- Cited by
- 1,099
- References
- 235
- FWCI
- 20.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.